No paralogue variants have been mapped to residue 671 for KCNH2.
KCNH2 | SICVMLIGSLMYASIFGNVSAIIQRLYSGT>A<RYHTQMLRVREFIRFHQIPNPLRQRLEEYF | 701 |
KCNH1 | AVAIMMIGSLLYATIFGNVTTIFQQMYANT>N<RYHEMLNSVRDFLKLYQVPKGLSERVMDYI | 540 |
KCNH3 | SICTMLIGALMHAVVFGNVTAIIQRMYARR>F<LYHSRTRDLRDYIRIHRIPKPLKQRMLEYF | 542 |
KCNH4 | SICTMLIGALMHAVVFGNVTAIIQRMYSRR>S<LYHSRMKDLKDFIRVHRLPRPLKQRMLEYF | 516 |
KCNH5 | SVAMMMVGSLLYATIFGNVTTIFQQMYANT>N<RYHEMLNNVRDFLKLYQVPKGLSERVMDYI | 509 |
KCNH6 | SICVMLIGSLMYASIFGNVSAIIQRLYSGT>A<RYHTQMLRVKEFIRFHQIPNPLRQRLEEYF | 553 |
KCNH7 | SICVMLIGSLMYASIFGNVSAIIQRLYSGT>A<RYHMQMLRVKEFIRFHQIPNPLRQRLEEYF | 704 |
KCNH8 | SICTMLIGALMHALVFGNVTAIIQRMYSRW>S<LYHTRTKDLKDFIRVHHLPQQLKQRMLEYF | 511 |
CNGA1 | VVVDFLIGVLIFATIVGNIGSMISNMNAAR>A<EFQARIDAIKQYMHFRNVSKDMEKRVIKWF | 438 |
CNGA2 | VIFDFLIGVLIFATIVGNVGSMISNMNATR>A<EFQAKIDAVKHYMQFRKVSKGMEAKVIRWF | 413 |
CNGA3 | VVVDFLVGVLIFATIVGNVGSMISNMNASR>A<EFQAKIDSIKQYMQFRKVTKDLETRVIRWF | 441 |
CNGA4 | MVGDFLLAVMGFATIMGSMSSVIYNMNTAD>A<AFYPDHALVKKYMKLQHVNRKLERRVIDWY | 307 |
CNGB1 | QLLNYFTGVFAFSVMIGQMRDVVGAATAGQ>T<YYRSCMDSTVKYMNFYKIPKSVQNRVKTWY | 921 |
CNGB3 | QLLNFFSGVFVFSSLIGQMRDVIGAATANQ>N<YFRACMDDTIAYMNNYSIPKLVQKRVRTWY | 483 |
HCN1 | TMLSMIVGATCYAMFVGHATALIQSLDSSR>R<QYQEKYKQVEQYMSFHKLPADMRQKIHDYY | 435 |
HCN2 | TMLSMIVGATCYAMFIGHATALIQSLDSSR>R<QYQEKYKQVEQYMSFHKLPADFRQKIHDYY | 504 |
HCN3 | TMLSMIVGATCYAMFIGHATALIQSLDSSR>R<QYQEKYKQVEQYMSFHKLPADTRQRIHEYY | 388 |
HCN4 | TMLSMIVGATCYAMFIGHATALIQSLDSSR>R<QYQEKYKQVEQYMSFHKLPPDTRQRIHDYY | 555 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.A671G | c.2012C>G | Putative Benign | SIFT: Polyphen: |